6 min read
1 min read
Veristat Launches A Flexible Virtual Clinical Trial Solution
Veristat Enhances Patient-Centricity Offering by Delivering Clinical Trials
Directly to Patients
SOUTHBOROUGH, MA – September 30, 2020 – Veristat, a scientific-minded global clinical research organization (CRO), announced today the launch of a virtual clinical trial solution that is flexible and customizable so that patient interactions can be conducted at the clinical site, remotely at-home, or through a hybrid combination of both strategies.
The time for virtual clinical trial adoption is now,” said Shaheen Limbada, Executive Vice President of Global Clinical Operations at Veristat, “The COVID-19 pandemic has disrupted clinical trial conduct and turned virtual trials into a necessary reality, with patients treated at their homes instead of a clinical site. Our flexible virtual trials approach eases the burden of clinical trial participation for the patient, allows trials stalled by COVID-19 restrictions to move forward, and improves overall clinical trial conduct efficiency.”
Veristat utilizes patient-centric practices to improve clinical trial participation by easing the burden on patients. Implementing virtual trials has undeniably benefited both patients and sponsors conducting clinical trials. For patients, it reduces the burden of travel time to a physical doctor’s office, clinic, or hospital site, which could be hours from home. It removes the geographic barrier of patient access to a site that may be too far from home altogether. For sponsors, the virtual trial approach improves patient recruitment and retention, and helps overcome future pandemic restrictions by utilizing at-home patient visits when in-person visits are not achievable.
The Veristat solution integrates our proven approaches to digital patient recruitment and retention strategies, at-home patient visits, and the ability to conduct virtual patient interactions throughout the clinical trial. Virtual trials require a higher degree of technology adoption and integration. A few examples include eConsent, ePRO, and eSource, which require training and integration to ensure the privacy, accuracy, and integrity of the data being collected.
We understand how challenging it is for drug developers to adopt a new way of conducting clinical trials and pivoting to virtual trials is no exception,” stated Patrick Flanagan, Chief Executive Officer at Veristat,"We offer our clients a flexible and proven virtual trial solution led by a team of scientific experts. They are helping clients adapt to a clinical trial landscape that is rapidly endorsing virtual clinical trials."
MEET VERISTAT. LEARN MORE.
- Need help considering which Virtual or Decentralized clinical trial solution works best for your clinical program? Let's Talk Today!
- Learn about our end-to-end suite of service offerings.
- Check out our podcast series Advancing Revolutionary Therapies
Get the Latest News
Categories
- Clinical Trials (17)
- Clinical Operations/Monitoring (11)
- Life At Veristat (11)
- Regulatory Submissions (11)
- Success Stories (11)
- Statistics and Programming (6)
- Clinical Trial Regulations (5)
- Medical Writing (5)
- Data Management (4)
- Events (4)
- Regulatory Consulting (4)
- Strategic Consulting (4)
- COVID-19 (3)
- Adaptive Design (2)
- Biometrics (2)
- Pharmacovigilance (2)
- Cell Gene and RNA (1)
- Decentralized Trials/Virtual Trials (1)
- Medical Monitoring (1)
- Project Management (1)
2 min read
ASCO Annual Meeting
Apr 23, 2025 Veristat Events
Meet Veristat at the 2025 ASCO Annual Meeting
Advancing Oncology Therapies for Patients in Need
Veristat is proud to...